Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Replimune Group, Inc. Director's Dealing 2019

Nov 20, 2019

33193_dirs_2019-11-20_b3a40b10-8a40-433a-9cc8-d4ce380168a8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2019-11-18

Reporting Person: Atlas Venture Opportunity Fund I, L.P. (See Remarks)
Reporting Person: Atlas Venture Associates Opportunity I, L.P. (See Remarks)
Reporting Person: Atlas Venture Associates Opportunity I, LLC (See Remarks)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1100000 Indirect

Footnotes

F1: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.